Literature DB >> 32144062

Extracorporeal Membrane Oxygenation During Adult Noncardiac Surgery and Perioperative Emergencies: A Narrative Review.

Theng Wai Foong1, Kollengode Ramanathan2, Kevin Kien Man Chan3, Graeme MacLaren2.   

Abstract

Over the last decade, the use of extracorporeal membrane oxygenation (ECMO) has increased significantly. In some centers, ECMO has been deployed to manage perioperative emergencies and plays a role in facilitating high-risk thoracic, airway, and trauma surgery, which may not be feasible without ECMO support. General anesthesiologists who usually manage these cases may not be familiar with the initiation and management of patients on ECMO. This review discusses the use of ECMO in the operating room for thoracic, airway, and trauma surgery, as well as obstetric and perioperative emergencies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  extracorporeal life support; extracorporeal membrane oxygenation; noncardiac surgery; perioperative emergencies

Mesh:

Year:  2020        PMID: 32144062     DOI: 10.1053/j.jvca.2020.01.025

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  3 in total

1.  Cardiopulmonary Resuscitation During the Coronavirus Crisis: Important Updates for the Cardiothoracic and Vascular Anesthesia Community.

Authors:  John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-04-28       Impact factor: 2.628

2.  Rescue extracorporeal membrane oxygenation for massive anterior mediastinal masses.

Authors:  Lowell Leow; Hari Kumar Sampath; Keith J Yong; Theo Kofidis; John Kit Chung Tam; Graeme MacLaren; Lynette Teo; Harish Mithiran; Kollengode Ramanathan
Journal:  J Artif Organs       Date:  2021-04-03       Impact factor: 1.731

3.  Relationship between 30 Days Mortality and Incidence of Intraoperative Cardiac Arrest According to the Timing of ECMO.

Authors:  Taehwa Kim; Seungeun Lee; Sungkwang Lee
Journal:  J Clin Med       Date:  2021-05-05       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.